David Barros-Sierra, Rodrigo Zepeda-Tello, Marcela Tamayo-Ortiz, Hector Osiris Gutiérrez-Díaz, Valeria Aurora Pérez-Chávez, José Antonio Rosa-Parra, Luis Enrique Nieto-Barajas, Mauricio Méndez-Aranda, Luis Alonso Herrera-Montalvo, Mauricio Hernández-Ávila
{"title":"SARS-CoV-2 seroprevalence and respiratory disease disability claims in Mexico City Metropolitan Area.","authors":"David Barros-Sierra, Rodrigo Zepeda-Tello, Marcela Tamayo-Ortiz, Hector Osiris Gutiérrez-Díaz, Valeria Aurora Pérez-Chávez, José Antonio Rosa-Parra, Luis Enrique Nieto-Barajas, Mauricio Méndez-Aranda, Luis Alonso Herrera-Montalvo, Mauricio Hernández-Ávila","doi":"10.21149/14545","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To characterize the impact of SARS-CoV-2 infection in workers from an essential large-scale company in the Greater Mexico City Metropolitan Area using point prevalence of acute infection, point prevalence of past infection through serum antibodies and respiratory disease short-term disability claims (RD-STDC).</p><p><strong>Materials and methods: </strong>Four randomized surveys, three during 2020 before and one after (December 2021) vaccines' availability.</p><p><strong>Outcomes: </strong>point prevalence of acute infection through saliva PCR (polymerase chain reaction) testing, point prevalence of past infection through serum antibodies against Covid-19, RD-STDC and prevalence of symptoms during the previous six months.</p><p><strong>Results: </strong>Prevalence of SARS-CoV-2 cases was 1.29-4.88%, on average, a quarter of participants pre-vaccination were seropositive; over half of participants with a RD-STDC had antibodies. The odds of having antibodies were 6-7 times more among workers with an RD-STDC.</p><p><strong>Conclusions: </strong>High antibody levels against Covid-19 in this study population reflects that coverage is high among workers in this industry. STDCs are a useful tool to track workplace epidemics.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21149/14545","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To characterize the impact of SARS-CoV-2 infection in workers from an essential large-scale company in the Greater Mexico City Metropolitan Area using point prevalence of acute infection, point prevalence of past infection through serum antibodies and respiratory disease short-term disability claims (RD-STDC).
Materials and methods: Four randomized surveys, three during 2020 before and one after (December 2021) vaccines' availability.
Outcomes: point prevalence of acute infection through saliva PCR (polymerase chain reaction) testing, point prevalence of past infection through serum antibodies against Covid-19, RD-STDC and prevalence of symptoms during the previous six months.
Results: Prevalence of SARS-CoV-2 cases was 1.29-4.88%, on average, a quarter of participants pre-vaccination were seropositive; over half of participants with a RD-STDC had antibodies. The odds of having antibodies were 6-7 times more among workers with an RD-STDC.
Conclusions: High antibody levels against Covid-19 in this study population reflects that coverage is high among workers in this industry. STDCs are a useful tool to track workplace epidemics.